Esteban Fernandez-Nogales
Sevilla, AN, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
High leptin levels independent of body mass index are associated with inflammation and poorer treatment response in patients with diffuse large B-cell lymphoma.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: October 01, 2025
Obesity and overweight in R/R DLBCL patients is associated with a better response to treatment of R2-GDP-GOTEL trial. Potential role of NK CD8 + cells and vitamin D.
Journal: Cancer & metabolism
Published: November 06, 2024
CD8+ NKs as a potential biomarker of complete response and survival with lenalidomide plus R-GDP in the R2-GDP-GOTEL trial in recurrent/refractory diffuse large B cell lymphoma.
Journal: Frontiers in immunology
Published: September 13, 2023
Lenalidomide plus R-GDP (R2-GDP) in Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Final Results of the R2-GDP-GOTEL Trial and Immune Biomarker Subanalysis.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: February 21, 2022
Publisher Correction: Circulating immune biomarkers in peripheral blood correlate with clinical outcomes in advanced breast cancer.
Journal: Scientific reports
Published: August 31, 2021
Circulating myeloid-derived suppressor cells and regulatory T cells as immunological biomarkers in refractory/relapsed diffuse large B-cell lymphoma: translational results from the R2-GDP-GOTEL trial.
Journal: Journal for immunotherapy of cancer
Published: May 08, 2021
Circulating immune biomarkers in peripheral blood correlate with clinical outcomes in advanced breast cancer.
Journal: Scientific reports
Published: February 09, 2021
Impact of intestinal dysbiosis-related drugs on the efficacy of immune checkpoint inhibitors in clinical practice.
Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
Published: November 15, 2019
Circulating regulatory T cells from breast cancer patients in response to neoadjuvant chemotherapy.
Journal: Translational cancer research
Published: July 27, 2018
New horizons in breast cancer: the promise of immunotherapy.
Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
Published: April 28, 2018
New insights into the role of the immune microenvironment in breast carcinoma.
Journal: Clinical & developmental immunology
Published: January 29, 2013
Last Updated: 09/26/2026